| Dr Randall William Leyking, DPM | |
|
21250 Hawthorne Blvd, Suite 160, Torrance, CA 90503-5506 | |
| (310) 540-1213 | |
| (310) 540-7405 |
| Full Name | Dr Randall William Leyking |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 17 Years |
| Location | 21250 Hawthorne Blvd, Torrance, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073834180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | #E4891 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - South Bay | Harbor city, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer, which has no treatment and detrimental outcomes in most cases.
While most adults have likely experienced the uncomfortable symptoms of heartburn at least once, for the 50 million American adults who suffer from frequent heartburn two or more days per week, the condition is not only painful, it can also impact their quality of life.
On Monday, Kessler Foundation became the second rehabilitation research center in the U.S. to implement Ekso, a wearable, robotic battery-powered exoskeleton that allows wheelchair users with lower-extremity weakness to stand and walk.
The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.
› Verified 3 days ago
| Provider Name | Southern California Permanente Medical Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer, which has no treatment and detrimental outcomes in most cases.
While most adults have likely experienced the uncomfortable symptoms of heartburn at least once, for the 50 million American adults who suffer from frequent heartburn two or more days per week, the condition is not only painful, it can also impact their quality of life.
On Monday, Kessler Foundation became the second rehabilitation research center in the U.S. to implement Ekso, a wearable, robotic battery-powered exoskeleton that allows wheelchair users with lower-extremity weakness to stand and walk.
The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Randall William Leyking, DPM 21250 Hawthorne Blvd, Suite 160, Torrance, CA 90503-5506 Ph: (310) 540-1213 | Dr Randall William Leyking, DPM 21250 Hawthorne Blvd, Suite 160, Torrance, CA 90503-5506 Ph: (310) 540-1213 |
News Archive
Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer, which has no treatment and detrimental outcomes in most cases.
While most adults have likely experienced the uncomfortable symptoms of heartburn at least once, for the 50 million American adults who suffer from frequent heartburn two or more days per week, the condition is not only painful, it can also impact their quality of life.
On Monday, Kessler Foundation became the second rehabilitation research center in the U.S. to implement Ekso, a wearable, robotic battery-powered exoskeleton that allows wheelchair users with lower-extremity weakness to stand and walk.
The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.
› Verified 3 days ago
Marc Alan Benard, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3812 Sepulveda Blvd, Suite 530, Torrance, CA 90505 Phone: 310-530-8001 Fax: 310-375-1386 | |
E.t. Foot & Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 23365 Hawthorne Blvd Ste 101, Torrance, CA 90505 Phone: 714-851-7775 | |
Arnold Serkin, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3400 Lomita Blvd Ste 403, Torrance, CA 90505 Phone: 310-326-8551 | |
Dr. Carl Wagreich, D.P.M. Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 23451 Madison St, Ste 230, Torrance, CA 90505 Phone: 310-373-0521 Fax: 310-791-1691 | |
Dr. Nina Argade, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 3655 Lomita Blvd, Ste 120, Torrance, CA 90505 Phone: 562-933-2000 | |
Focused Foot Care Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 17521 Crenshaw Blvd, Torrance, CA 90504 Phone: 310-963-6229 |